Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"
Sharon E Johnatty, Jonathan Beesley, Xiaoqing Chen, Stuart Macgregor, David L Duffy, Amanda B Spurdle, Anna deFazio, Natalie Gava, Penelope M Webb, Mary Anne Rossing, Jennifer Anne Doherty, Marc T Goodman, Galina Lurie, Pamela J Thompson, Lynne R Wilkens, Roberta B Ness, Kirsten B Moysich, Jenny Chang-Claude, Shan Wang-Gohrke, Daniel W CramerKathryn L Terry, Susan E Hankinson, Shelley S Tworoger, Montserrat Garcia-Closas, Hannah Yang, Jolanta Lissowska, Stephen J Chanock, Paul D Pharoah, Honglin Song, Alice S Whitemore, Celeste L Pearce, Daniel O Stram, Anna H Wu, Malcolm C Pike, Simon A Gayther, Susan J Ramus, Usha Menon, Aleksandra Gentry-Maharaj, Hoda Anton-Culver, Argyrios Ziogas, Estrid Hogdall, Susanne K Kjaer, Claus Hogdall, Andrew Berchuck, Joellen M Schildkraut, Edwin S Iversen, Patricia G Moorman, Catherine M Phelan, Thomas A Sellers, Julie M Cunningham, Ovarian Cancer Association Consortium
Dive into the research topics of 'Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"'. Together they form a unique fingerprint.